NORDEA INVESTMENT MANAGEMENT ABNORDEA INVESTMENT MANAGEMENT AB

Institutional investor · Portfolio as of Q2 2019

Top Holdings974 positions

Checking export access…
Activity:

Johnson & Johnson

8.6M$1.2B2.7%$113.77+0.32%
2 qtrssince 2019-Q1
Decreased
0

Microsoft Corp

8.6M$1.1B2.6%$110.12+14.00%
2 qtrssince 2019-Q1
Decreased
0

Medtronic PLC

10.2M$990.6M2.2%$74.34+5.81%
2 qtrssince 2019-Q1
Increased
64

Cisco Systems Inc/Delaware

17.7M$968.8M2.2%$43.51+2.01%
2 qtrssince 2019-Q1
Decreased
0

Apple Inc

4.9M$965.4M2.2%$45.22+4.60%
2 qtrssince 2019-Q1
Decreased
0

Amgen Inc

4.9M$898.5M2.0%$151.26-2.09%
2 qtrssince 2019-Q1
Increased
56

AT&T Inc

24.9M$836M1.9%$14.13+7.68%
2 qtrssince 2019-Q1
Increased
58

Halfmoon Parent Inc

4.8M$764.1M1.7%$143.87-1.50%
2 qtrssince 2019-Q1
Increased
65

Alphabet Inc

698,437$756.6M1.7%$55.74-3.79%
2 qtrssince 2019-Q1
Increased
81

Comcast Corp

17.8M$753.1M1.7%$29.86+6.11%
2 qtrssince 2019-Q1
Increased
51

Pfizer Inc

15.7M$681.1M1.5%$28.06+2.91%
2 qtrssince 2019-Q1
Decreased
0

Oracle Corp

11.6M$662M1.5%$48.13+6.54%
2 qtrssince 2019-Q1
Decreased
0

Anthem Inc

2.3M$649.6M1.4%$258.46-1.38%
2 qtrssince 2019-Q1
Decreased
0

Cognizant Technology Solutions

9.8M$623.9M1.4%$64.35-12.21%
2 qtrssince 2019-Q1
Decreased
0

Merck & Co Inc

7.4M$621.3M1.4%$63.04+1.45%
2 qtrssince 2019-Q1
Increased
51

CVS Health Corp

11M$599.6M1.3%$42.32+2.01%
2 qtrssince 2019-Q1
Decreased
0

JPMorgan Chase & Co

5M$563.1M1.3%$82.70+11.29%
2 qtrssince 2019-Q1
Decreased
0

Chubb Ltd

3.8M$563M1.3%$124.67+5.68%
2 qtrssince 2019-Q1
Decreased
0

Amazon.com Inc

272,285$515.8M1.1%$89.05+6.32%
2 qtrssince 2019-Q1
Increased
49

International Business Machine

3.6M$490.9M1.1%$98.59-1.11%
2 qtrssince 2019-Q1
Decreased
0
$44.9B
AUM
974
Positions
Q2 2019
Filing
HI score · 2.0/5
Quarterly 13F Value Change
Not enough history yet
Activity profile
$ moved · Q2'19
New5%Increased30%Decreased49%Exited17%
Composition
Equity vs derivatives
Equity100%Puts0%Calls0%
Holding period
Avg <1 quarter
<1Q4%1-4Q96%1-2Y0%2Y+0%

NORDEA INVESTMENT MANAGEMENT AB manages $44.9B across 974 positions as of Q2 2019. Top holdings: JNJ (2.7%), MSFT (2.6%), MDT (2.2%). Fund DNA: Steady Compounder. HoldingsIntel Score: 2/5.0.

Q2 2019 Summary

Active quarter - 40 new positions, 439 exits, 264 increased. Top move: GOOGL (INCREASED, conviction 81). Portfolio: $44.9B across 974 positions.

Top holdings by portfolio weight

Total AUM$45B
JNJ2.68%
MSFT2.56%
MDT2.21%
CSCO2.16%
AAPL2.15%
AMGN2.00%
T1.86%
CI1.70%
GOOGL1.69%
CMCSA1.68%
Other1.52%

Portfolio allocation by GICS sector

Sectors11
Healthcare21.95%
Technology18.99%
Financial Services14.24%
Consumer Cyclical10.03%
Communication Services9.54%
Industrials5.90%
Unknown4.89%
Consumer Defensive4.83%
Utilities3.00%
Energy2.60%
Other4.02%

Behavioral investing profile

Checking access…
Steady Compounder- primarily Healthcare, Technology, Financial Services
Compare DNA across all funds
7-dimension, SEC 13F-derived research score
Below Average(2.0 / 5.0)
Holdings P&L57
Conviction41
Concentration48
Checking access…

Position Outcomes

Best and worst performing positions by estimated return

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Similar Funds

Funds with similar investing DNA

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

Security
7Q
ABTABTAbbott Laboratories
Q4 2024 → Q2 2026+531,236 shares+$44.6M
7Q
ALNYALNYALNYLAM PHARMACEUTICALS INC
Q4 2024 → Q2 2026+17,362 shares+$5.4M
7Q
GOOGGOOGAlphabet Inc.
Q4 2024 → Q2 2026+2.4M shares+$2B
Checking access…

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Verify source filings on SEC EDGAR

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used